Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

BUY
$1.8 - $2.83 $28 - $45
16 New
16 $0
Q3 2022

Nov 10, 2022

SELL
$0.94 - $5.99 $378 - $2,413
-403 Reduced 14.08%
2,460 $12,000
Q2 2022

Aug 03, 2022

BUY
$3.2 - $5.69 $28 - $51
9 Added 0.32%
2,863 $13,000
Q1 2022

May 04, 2022

BUY
$2.8 - $7.39 $7,991 - $21,091
2,854 New
2,854 $11,000

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.